Видео с ютуба Lenalidomide

Lenalidomide's place in the myeloma treatment landscape

Lenalidomid (Revlimid) – lek immunomodulujący (IMiD) w leczeniu szpiczaka mnogiego

What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?

The impact of lenalidomide on second primary malignancies: long-term data from the Myeloma XI Trial

Lenalidomide for smoldering myeloma

Lenalidomide maintenance – an active approach to treating MM?

Dr. Leonard on Lenalidomide With Rituximab in Follicular Lymphoma

Lenalidomide in hematologic malignancies - Video abstract [ID 81310]

Lenalidomide as a Highly-Effective Maintenance Therapy in Myeloma

Graham Jackson, MD: Lenalidomide Maintenance Is Effective in All Types of Myeloma Patients

Toxicities Associated With Lenalidomide for Multiple Myeloma

OPTIMISMM: investigating an alternative therapy for lenalidomide-refractory patients

Benefit of treating smouldering myeloma patients early with lenalidomide & dexamethasone

Novel Anti-Cancer Agents for Multiple Myeloma

Dr. Schuster on Long-Term Outcomes of Lenalidomide and Rituximab in MCL

Results of RELEVANCE: frontline rituximab-lenalidomide for follicular lymphoma

Lenalidomide maintenance remains best for newly diagnosed MM

Should I interrupt or discontinue therapy in patients with lenalidomide-induced rash?

Dr. LaCasce Discusses the FDA Approval of Lenalidomide/Rituximab in Non-Hodgkin Lymphoma

AFT-41 trial: daratumumab, lenalidomide, ixazomib, and dexamethasone in transplant-ineligible NDMM